ICU Medical (NASDAQ:ICUI) Lowered to Hold at ValuEngine

Share on StockTwits

ValuEngine cut shares of ICU Medical (NASDAQ:ICUI) from a buy rating to a hold rating in a research report released on Tuesday morning, ValuEngine reports.

A number of other analysts have also recently weighed in on the company. TheStreet cut ICU Medical from a b- rating to a c+ rating in a research report on Monday, August 12th. BidaskClub raised ICU Medical from a hold rating to a buy rating in a research report on Thursday, November 21st. Zacks Investment Research cut ICU Medical from a hold rating to a sell rating in a research report on Wednesday, August 14th. Finally, Raymond James raised their price objective on ICU Medical from $185.00 to $203.00 and gave the stock a positive rating in a research report on Tuesday, November 12th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $242.00.

Shares of ICU Medical stock traded down $2.71 during trading on Tuesday, reaching $179.39. The company’s stock had a trading volume of 1,123 shares, compared to its average volume of 210,040. The company has a market cap of $3.69 billion, a price-to-earnings ratio of 23.20 and a beta of 0.92. ICU Medical has a 1-year low of $148.89 and a 1-year high of $259.72. The company has a 50-day simple moving average of $175.71 and a two-hundred day simple moving average of $195.04.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Monday, November 11th. The medical instruments supplier reported $1.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.62 by $0.03. The firm had revenue of $307.47 million during the quarter, compared to analysts’ expectations of $297.83 million. ICU Medical had a return on equity of 12.13% and a net margin of 5.66%. The business’s quarterly revenue was down 6.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.85 EPS. As a group, equities analysts predict that ICU Medical will post 7.1 EPS for the current year.

In other news, Director George A. Lopez sold 20,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $184.29, for a total value of $3,685,800.00. Following the completion of the transaction, the director now owns 368,864 shares of the company’s stock, valued at approximately $67,977,946.56. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Scott E. Lamb sold 9,185 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $180.58, for a total value of $1,658,627.30. Following the completion of the transaction, the chief financial officer now directly owns 22,494 shares of the company’s stock, valued at approximately $4,061,966.52. The disclosure for this sale can be found here. In the last three months, insiders sold 29,558 shares of company stock valued at $5,401,679. Insiders own 11.40% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Municipal Employees Retirement System of Michigan lifted its holdings in shares of ICU Medical by 1.3% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 3,070 shares of the medical instruments supplier’s stock valued at $773,000 after buying an additional 40 shares during the period. Advisory Services Network LLC lifted its holdings in shares of ICU Medical by 70.2% in the 2nd quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 59 shares during the period. Huntington National Bank lifted its holdings in shares of ICU Medical by 17.9% in the 3rd quarter. Huntington National Bank now owns 559 shares of the medical instruments supplier’s stock valued at $89,000 after buying an additional 85 shares during the period. Steward Partners Investment Advisory LLC increased its stake in shares of ICU Medical by 8.4% in the 3rd quarter. Steward Partners Investment Advisory LLC now owns 1,628 shares of the medical instruments supplier’s stock valued at $259,000 after purchasing an additional 126 shares in the last quarter. Finally, Metropolitan Life Insurance Co NY increased its stake in shares of ICU Medical by 2.4% in the 3rd quarter. Metropolitan Life Insurance Co NY now owns 5,654 shares of the medical instruments supplier’s stock valued at $902,000 after purchasing an additional 135 shares in the last quarter. 91.85% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Story: What are Institutional Investors?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Clean Yield Group Lowers Stock Holdings in Quest Diagnostics Inc
Clean Yield Group Lowers Stock Holdings in Quest Diagnostics Inc
Clean Yield Group Decreases Stock Position in General Electric
Clean Yield Group Decreases Stock Position in General Electric
Clean Yield Group Grows Stock Holdings in iShares Core S&P Mid-Cap ETF
Clean Yield Group Grows Stock Holdings in iShares Core S&P Mid-Cap ETF
iShares Agency Bond ETF  Shares Bought by Clean Yield Group
iShares Agency Bond ETF Shares Bought by Clean Yield Group
Clean Yield Group Has $452,000 Position in First Solar, Inc.
Clean Yield Group Has $452,000 Position in First Solar, Inc.
Clean Yield Group Buys 2,884 Shares of AFLAC Incorporated
Clean Yield Group Buys 2,884 Shares of AFLAC Incorporated


 
© 2006-2020 Zolmax.